Hemostemix owns over 91 patentsThe Company owns 91 patents across five patent families titled: Regulating Stem Cells, In Vitro Techniques for use with Stem Cells, Production from Blood of Cells of Neural Lineage, and Automated Cell Therapy.
https://www.newsfilecorp.com/redirect/VmKbBSxmVP